Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: hormonal contraceptives

Hormonal Contraceptives Increase Breast Cancer Risk, New Study Finds



A study published last week in The New England Journal of Medicine has found that hormonal contraceptives, including oral contraceptive pills and hormone-releasing IUDs, significantly increase women’s risk for breast cancer. The study found that women who used hormonal contraception had a 20 percent elevated risk[1] for breast cancer compared to women who had never used a hormonal method. The risk was also found to be time-dependent, increasing the longer the hormonal drugs were used. …

Read more.




PRI Review 2016, (v26, n6) November/December



The Abortion Movement Just Lost 1 My Orders are to Fight 2 CRS Activity in the D.R. Congo 3 May I Send You This Gift? 4 Scholars Rally to Defend Truth 6 Global Monitor 7 Do Not Mess With My Children 8 PRI in the News 9 Mandatory Birth Control 10 Welcome, Baby Rosie! 11 Hichborn Raises Questions 12

Read more.




Natural Family Planning



Our new video addresses a form of fertility management that is cost-free, pill-free, and free of coercion. The new video is titled: “Natural Family Planning: the Best Worst Thing Ever.” Watch the video. Get the facts. Share with friends. “You can sacrifice frequency, taking time off during fertile periods.”             While men are always fertile, women are only fertile a short period of time during each menstrual cycle (about 28-31 days). …

Read more.




Global Monitor



Contraceptive Watch: Johnson & Johnson Has Paid $68 Million to Date to Women Harmed by the Ortho Evra Patch Bloomberg News reported on October 10 that Johnson & Johnson has spent at least $68.7 million to settle hundreds of lawsuits filed by women who suffered blood clots, heart attacks or strokes after using the company’s Ortho Evra birth-control patch. The company, which is the world’s largest maker of health-care products, used confidential settlements to avoid …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.